Will PFE stock split soon?
Apr 03, 2022 · Stock Exchange NYSE Industry Pharmaceutical preparations Sub-Industry Pharmaceuticals Sector Medical Current Symbol NYSE:PFE Previous Symbol CUSIP 71708110 CIK 78003 Web www.pfizer.com Phone (212) 733-2323 Fax 302-655-5049 Employees 79,000 Year Founded 1849 Sales & Book Value Annual Sales $81.29 billion Price / Sales 3.83 Cash Flow …
Is Pfizer Inc. (PFE) a good stock to buy?
Pfizer (PFE) New York Stock Exchange PFE $54.19 -$0.32 -0.6% Price as of March 21, 2022, 4:00 p.m. ET View Interactive PFE Charts A research-based pharmaceutical company, Pfizer …
Why is PFE going down?
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate.
Why is PFE falling?
Apr 11, 2022 · The Pfizer Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $52.99 and $50.88.
How high is PFE stock expected to go?
Stock Price Forecast The 20 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 57.00, with a high estimate of 76.00 and a low estimate of 49.00. The median estimate represents a +7.34% increase from the last price of 53.10.
Is PFE a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.93%2Buy18.44%3Hold9.99%4Sell5.61%2 more rows
Is PFE part of Nasdaq?
Common Stock (PFE) Stock Price, Quote, News & History | Nasdaq....Key Data.LabelValueForward P/E 1 Yr.7.58Earnings Per Share(EPS)$3.85Annualized Dividend$1.60Ex Dividend DateJan 27, 202214 more rows
What stock sector is PFE?
Pfizer's sector is Healthcare.
What is Zacks rating on Pfizer?
PFE 52.87 +1.63(3.18%) Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that nearly triples the S&P 500.
Why is PFE down?
Pfizer CEO Albert Bourla talks. Pfizer shares dropped sharply after the company's 2022 sales guidance appeared to fall short of expectations. The guidance that Pfizer (ticker: PFE) presented, however, doesn't take into account future sales of Pfizer's Covid-19 vaccine and antiviral, but only sales already made.Feb 9, 2022
Who holds Pfizer shares?
The top shareholders of Pfizer are Frank A. D'amelio, John Douglas Young, Mikael Dolsten, Vanguard Group Inc., BlackRock Inc. (BLK), and State Street Corp.
Is Pfizer a private company?
Pfizer would remain a privately held company until June 22, 1942, when 240,000 shares of new common stock were offered to the public.
Is Pfizer publicly traded?
As a publicly-traded company, you can view Pfizer's annual and quarterly reports on its investor relations website or on the Securities and Exchange Commission (SEC) database. In 2021, Pfizer reported full-year revenues of $81.3 billion.Mar 21, 2022
What does Pfizer Inc do?
We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.
What drugs are made by Pfizer?
Pfizer Inc. is a pharmaceutical company that created many well-known drugs. Pfizer brands include Advil, Bextra, Celebrex, Diflucan, Lyrica, Robitussin and Viagra. The Big Pharma company is also the mastermind behind many popular consumer products.
Is Pfizer a buy right now?
19 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 9 hold ratings and...
How has Pfizer's stock been impacted by Coronavirus (COVID-19)?
Pfizer's stock was trading at $32.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organiza...
When is Pfizer's next earnings date?
Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for Pfizer .
How were Pfizer's earnings last quarter?
Pfizer Inc. (NYSE:PFE) released its earnings results on Tuesday, February, 8th. The biopharmaceutical company reported $1.08 EPS for the quarter, b...
How often does Pfizer pay dividends? What is the dividend yield for Pfizer?
Pfizer announced a quarterly dividend on Friday, December 10th. Stockholders of record on Friday, January 28th will be paid a dividend of $0.40 per...
Is Pfizer a good dividend stock?
Pfizer pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.02%. Pfizer has been increasing its dividend for 12 conse...
What guidance has Pfizer issued on next quarter's earnings?
Pfizer issued an update on its FY 2022 earnings guidance on Tuesday, February, 22nd. The company provided EPS guidance of $6.350-$6.550 for the per...
What price target have analysts set for PFE?
19 Wall Street analysts have issued twelve-month target prices for Pfizer's stock. Their forecasts range from $44.00 to $76.00. On average, they an...
Who are Pfizer's key executives?
Pfizer's management team includes the following people: Dr. Albert Bourla D.V.M. , DVM, Ph.D., Chairman & CEO (Age 60, Pay $7.99M) Mr. Frank A....
4.3 Analyst's Opinion
Is Pfizer a buy right now?
Pfizer has received a consensus rating of Buy. The company's average rating score is 2.53, and is based on 10 buy ratings, 9 hold ratings, and no sell ratings.
How has Pfizer's stock been impacted by Coronavirus (COVID-19)?
19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last twelve months. There are currently 9 hold ratings and 10 buy ratings for the stock.
When is Pfizer's next earnings date?
Pfizer's stock was trading at $32.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PFE shares have increased by 42.9% and is now trading at $45.98. View which stocks have been most impacted by COVID-19.
How were Pfizer's earnings last quarter?
Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, May 3rd 2022. View our earnings forecast for Pfizer.
How often does Pfizer pay dividends? What is the dividend yield for Pfizer?
Pfizer Inc. (NYSE:PFE) released its quarterly earnings data on Monday, February, 7th. The biopharmaceutical company reported $1.08 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.87 by $0.21.
Is Pfizer a good dividend stock?
Pfizer announced a quarterly dividend on Friday, December 10th. Stockholders of record on Friday, January 28th will be paid a dividend of $0.40 per share on Friday, March 4th. This represents a $1.60 annualized dividend and a dividend yield of 3.48%. The ex-dividend date is Thursday, January 27th.
New York Stock Exchange
Pfizer pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.37%. Pfizer has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Pfizer is 47.62%.
Environmental, Social, and Governance Rating
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
COVID-19 shot interval can be extended to 8 weeks for some -U.S. CDC
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
Sanofi-Glaxo Vaccine May Threaten Pfizer, Moderna in Covid-19 Booster Market
Extending the interval between the first two doses of the most widely used COVID-19 vaccines in the country to eight weeks for young men can reduce the rare risk of heart inflammation, U.S. health officials said.
Signals & Forecast
Sanofi and GlaxoSmithKline plan to submit their long-awaited Covid-19 vaccine for regulatory approval. Data suggest it's a contender against Pfizer and Moderna boosters.
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The Pfizer Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is Pfizer Inc stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Insiders are negative selling more shares than they are buying in Pfizer Inc
Pfizer Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
About Pfizer Inc
In the last 100 trades there were 418.15 thousand shares bought and 817.18 thousand shares sold. The last trade was done 6 days ago by Johnson Rady A who bough 190 shares. In general the insiders are selling more stocks than they buy. There can be a variety of reasons for this, but in general it can be considered as a negative signal.
Golden Star Signal
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
When is Pfizer's next dividend payment?
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
When was Pfizer's most recent dividend payment?
Pfizer's next quarterly dividend payment of $0.40 per share will be made to shareholders on Friday, March 4, 2022.
What track record does Pfizer have of raising its dividend?
Pfizer's most recent quarterly dividend payment of $0.39 per share was made to shareholders on Monday, December 6, 2021.
When did Pfizer last increase or decrease its dividend?
Pfizer (NYSE:PFE) has increased its dividend for the past 12 consecutive years.
Pfizer Inc. - Hold
The most recent change in Pfizer's dividend was an increase of $0.01 on Friday, December 10, 2021.
Style Scorecard
Zacks' proprietary data indicates that Pfizer Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the PFE shares relative to the market in the next few months. In addition, Pfizer Inc.
Chart for PFE
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
There are two main reasons. At least one of them, though, isn't a problem anymore
With eight blockbuster products in its portfolio, New York-based, Pfizer, Inc. boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines.
NYSE: PFE
Last year, the major market indexes skyrocketed. But not Pfizer ( PFE -2.06% ). The big pharma stock actually fell slightly. And the downtrend has continued into this year. In this Motley Fool Live video, recorded on Feb. 17, Fool.com contributors Keith Speights and Brian Orelli answer a viewer's question about why Pfizer stock has floundered.
Premium Investing Services
Keith Speights: Ben asked the question, "Why is it that Pfizer," ticker there is PFE, "Why is it that Pfizer is down?" I have not looked at Pfizer stock this morning Let's see what's going on.
